- Home
- AMIX vs SINT Comparison
AMIX vs SINT Comparison
Compare AMIX & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMIX
- SINT
- Stock Information
- Founded
- AMIX 2014
- SINT 1996
- Country
- AMIX United States
- SINT United States
- Employees
- AMIX N/A
- SINT N/A
- Industry
- AMIX
- SINT Medical/Dental Instruments
- Sector
- AMIX
- SINT Health Care
- Exchange
- AMIX NYSE
- SINT Nasdaq
- Market Cap
- AMIX 4.9M
- SINT 4.8M
- IPO Year
- AMIX N/A
- SINT 2014
- Fundamental
- Price
- AMIX $1.95
- SINT $3.16
- Analyst Decision
- AMIX Strong Buy
- SINT Strong Buy
- Analyst Count
- AMIX 1
- SINT 1
- Target Price
- AMIX $5.00
- SINT $30.00
- AVG Volume (30 Days)
- AMIX 347.1K
- SINT 77.7K
- Earning Date
- AMIX 05-30-2025
- SINT 05-15-2025
- Dividend Yield
- AMIX N/A
- SINT N/A
- EPS Growth
- AMIX N/A
- SINT N/A
- EPS
- AMIX N/A
- SINT N/A
- Revenue
- AMIX N/A
- SINT $2,569,000.00
- Revenue This Year
- AMIX N/A
- SINT $3.26
- Revenue Next Year
- AMIX N/A
- SINT $21.87
- P/E Ratio
- AMIX N/A
- SINT N/A
- Revenue Growth
- AMIX N/A
- SINT N/A
- 52 Week Low
- AMIX $1.52
- SINT $1.71
- 52 Week High
- AMIX $75.80
- SINT $45.60
- Technical
- Relative Strength Index (RSI)
- AMIX 50.80
- SINT 59.97
- Support Level
- AMIX $1.67
- SINT $3.02
- Resistance Level
- AMIX $1.96
- SINT $3.69
- Average True Range (ATR)
- AMIX 0.21
- SINT 0.33
- MACD
- AMIX -0.01
- SINT 0.10
- Stochastic Oscillator
- AMIX 24.35
- SINT 59.85
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.